Evolving a Therapy Manufacturer's Genetic Testing Program for a Rare Solid Tumour
A small innovative medicines company used KeyOps to survey 24 medical oncologists on FGFR2 genetic testing knowledge and access for a rare cholangiocarcinoma therapy.
Cross-Border Insights: Surveying US and Canadian Otolaryngologists
A top US pharmaceutical company surveyed 70 ENTs across the US and Canada to assess rare disease awareness — delivering critical go-to-market intelligence in Fall 2024.
BioSyent Maximizes Investment in Market Research
How BioSyent leveraged KeyOps' on-demand insights platform to unlock physician perspectives that drove smarter marketing decisions and maximized research ROI.
Pharma Marketer Leverages Targeted Oncologist Insights
A pharmaceutical marketing team needed rapid oncologist feedback during a competitive launch window. KeyOps delivered specialty-targeted insights in under a week.
Faster Insights Yield Powerful Results
A global pharmaceutical executive transforms her team's research approach — getting physician insights in days, not months, with 80% response in under 48 hours.
.jpg)
How Asynch Can Help Make New Product Launches Smarter
Asynchronous research gives launch teams the physician input they need — on their schedule, not a conference room's. Here's how async changes the launch playbook.
How Large Pharma Co. Used KoLab to Build New Advisory Relationships
A large pharmaceutical company turned to KoLab to expand their HCP advisory network — and discovered faster setup, richer dialogue, and stronger ongoing engagement.
The Future of Pharma-to-Physician Engagement
The way pharma brands connect with physicians is changing fast. Here's where the industry is headed — and what teams need to do to stay ahead of the shift.
Don't Let Your Advisory Board Get Swiftied
When everyone's competing for the same HCP time and attention, the risk of getting crowded out is real. Here's how to keep your advisory board relevant and engaged.
.png)
New Product: KoLab
Introducing KoLab — KeyOps's digital advisory suite designed to replace traditional advisory boards with faster, richer, AI-assisted async HCP collaboration.
3 Ways to Improve Pharma Sales Force Effectiveness
With physician access tighter than ever, pharma sales teams need smarter strategies. Here are three ways real-time HCP insights can sharpen field force performance.
Drug Repurposing: When New Indications Create New Sales Opportunities
When an existing drug earns a new indication, it's a major commercial opportunity — one that requires rapid physician education and sharp market intelligence.
How to Capitalize on the Top 3 Factors Behind a Successful Product Launch
Product launches live or die on physician adoption. Here are the three factors that consistently separate high-performing launches — and how to act on them.
KeyOps Customer Engagement Platform
A look at how the KeyOps platform connects life sciences teams with peer-referred HCPs for faster, higher-quality insights at every stage of the brand lifecycle.
Leveraging Real-Time Physician Insights Throughout the Pharma Product Life Cycle
From pre-launch planning to post-market strategy, real-time HCP insights can inform every stage — if you have the right research infrastructure in place.
ATU Market Research: Why High-Cost Studies Fall Short on Value
Awareness, trial, and usage studies are a staple of pharma research — yet many teams walk away frustrated. Here's why the traditional ATU model is broken.
Implementing Digital Transformation in Life Sciences Market Research
The life sciences industry is embracing digital tools — but market research has been slow to follow. Here's what a modern approach actually looks like.
A Trusted Partner: How KeyOps Navigates the Procurement Process
Vendor onboarding in pharma can take months. KeyOps has built a process that gets compliance cleared in under six weeks — without sacrificing rigour.
Should Physician Advisory Board Research Be Trusted?
Advisory boards generate valuable input — but how reliable is that data, really? A closer look at the bias and structural limitations shaping what physicians say.
Reduce Time to Insight with KeyOps
Life sciences teams are under pressure to move faster. Here's how KeyOps is helping brands cut the time from question to actionable physician insight.
Re-Imagining Ad Boards
Advisory boards have long been a cornerstone of pharma strategy — but the traditional format is overdue for a rethink. Dr. Saeed Darvish on what the future looks like.
Here's why your physician engagement sucks
For cardiologist Dr. Saeed Darvish, the engagement between physicians and life sciences companies is broken — and a shift is in the air.
We asked 103 gastroenterologists in the U.S. for their opinion on CDI
103 US-based gastroenterologists on C. difficile diagnosis, testing modalities, FMT donor sources, barriers to adoption, and the future of microbiome-based therapeutics.
Preparing for a New Treatment in Atopic Dermatitis
42 dermatologists across Canada on treatment positioning, patient diversity, dupilumab preferences, abrocitinib adoption, and facial/periocular dermatitis management.
Navigating JAKi Clinical Safety in Rheumatoid Arthritis
21 Canadian Rheumatologists on JAK inhibitor use, tofacitinib safety data, treatment algorithm changes, and patient stratification in moderate to severe RA.
The Results of GI Biosimilars Transitions in Quebec
12 Quebec Gastroenterologists share their experiences transitioning patients to biosimilars, PSP support gaps, and concerns about RAMQ electronic submission mandates.
The Great Physician Indignation
50 Ontario Family Physicians on increased patient hostility and aggression in the clinic — 84% report hostilities have increased, 89% experienced anger or verbal aggression in the past 6 months.
Drug Access and Funding Survey Results
90 oncologists share their perspectives on drug access, pCODR submissions, CDR funding recommendations, and barriers to accessing reimbursed therapies in Canada.
What do physicians think of Vaccine Certification Programs?
250 physicians share their views on vaccine passports, national policy, frontline worker mandates, and whether certifications can help avoid lockdowns.
How has the pandemic affected dermatologists?
54 dermatologists from across Canada shared how the pandemic affected their practice — from patient volumes to virtual care challenges and skin cancer detection delays.
Changes in Canadian Endoscopy Units during pandemic
Survey findings from 34 respondents representing 25 endoscopy centres and hospitals across Canada, examining policy changes and volume impacts during the third wave.
KeyOps and ACTO Launch Real-Time HCP Insights Integration
A new partnership brings frontline physician voice directly into ACTO's IFE™ platform, enabling agile strategy and execution for commercial field teams.
KeyOps Joins MaRS Growth Services Portfolio
KeyOps was accepted into the Growth Services Portfolio at MaRS Discovery District — Toronto's world-renowned innovation hub for health tech companies.
KeyOps Donates to SickKids Foundation
KeyOps donated $500 to SickKids Foundation following physician participation in a research survey — a reflection of our commitment to giving back to the communities that trust us.
Residential School Donation
On Canada's first National Day for Truth and Reconciliation, KeyOps honours the lost children and survivors of the residential school system with a donation to the Indian Residential School Survivors Society.
Canadian Cancer Society Donation
To celebrate National Cancer Survivors Month, KeyOps hosted a contest for oncologists and donated $600 to the Canadian Cancer Society.